Form 4: Inhibrx Biosciences Director Buys Shares
Insider Transaction (Form 4)
Jon Faiz Kayyem, a Director of Inhibrx Biosciences, Inc., purchased 5,000 shares of common stock on September 23, 2026 for $100.00 per share.
Summary
- Open-market purchase: acquired 5,000 Common Stock at $100.00 ($500,000) on September 23, 2026; holds 434,360 after (Indirect).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $500,000, committing personal capital to the stock.
Insider Transactions
Jon Faiz Kayyem — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-23 | Open-market purchase | Common Stock | 5,000 | $100 | $500.0K | 434,360 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-23 | Open-market purchase (5,000 shares) |
Keywords
insider transaction, Form 4, INBX, Inhibrx Biosciences, Inc., bullish, Jon Faiz Kayyem
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.